Anne Wojcicki regains control of 23andMe, the company she co-founded and led as CEO, through her nonprofit TTAM with a $305 million bid at a bankruptcy auction.

Former 23andMe CEO Anne Wojcicki now runs TTAM Research Institute, which outbid Regeneron in an auction for the bankrupt ...

In a surprise twist, 23andMe founder and former CEO Anne Wojcicki is set to regain control of the DNA company's assets, according to a press release from 23andMe.

Anne Wojcicki, the co-founder and former CEO of 23andMe MEHCQ -0.51%, is poised to regain control of the DNA-testing company after a nonprofit she controls topped a prior bid.

Anne Wojcicki, chief executive officer and co-founder of 23andMe Inc., speaks during the 2020 Makers Conference in Los Angeles, California, U.S., on Tuesday, Feb. 11, 2020. Getty Images© Getty Images ...

In a surprise twist, 23andMe founder and former CEO Anne Wojcicki is set to regain control of the DNA company's assets, according to a press release from 23andMe. In May, a company called ...

Former 23andMe CEO Anne Wojcicki is set to regain control of the genetic testing firm she led to bankruptcy after outbidding a pharmaceutical company at an auction. The sale came on Monday after a ...

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' offer for the DNA-testing company in a bankruptcy auction.

(Reuters) -Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' offer for the DNA-testing company in a ...

Anne Wojcicki, the co-founder and former CEO of 23andMe MEHCQ -0.51%, is poised to regain control of the DNA-testing company after a nonprofit she controls topped a prior bid. 23andMe said Friday ...

(Reuters) -Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron (NASDAQ:REGN) Pharmaceuticals’ offer for the DNA-testing ...